| __timestamp | Protagonist Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 2395000 |
| Thursday, January 1, 2015 | 11831000 | 9057000 |
| Friday, January 1, 2016 | 25705000 | 40818000 |
| Sunday, January 1, 2017 | 46181000 | 79309000 |
| Monday, January 1, 2018 | 59497000 | 134428000 |
| Tuesday, January 1, 2019 | 65003000 | 175431000 |
| Wednesday, January 1, 2020 | 74506000 | 130944000 |
| Friday, January 1, 2021 | 126006000 | 121875000 |
| Saturday, January 1, 2022 | 126215000 | 115856000 |
| Sunday, January 1, 2023 | 120161000 | 130009000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Protagonist Therapeutics, Inc. and Wave Life Sciences Ltd. have demonstrated significant investments in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Protagonist Therapeutics increased its R&D expenses by over 1,500%, peaking in 2022. This growth underscores their strategic focus on developing novel peptide-based therapies.
Wave Life Sciences, on the other hand, saw a remarkable 5,300% increase in R&D spending during the same period, with a notable peak in 2019. This surge highlights their commitment to pioneering stereopure oligonucleotide therapies.
Both companies exemplify the biotech industry's relentless pursuit of innovation, with R&D spending trends offering a glimpse into their future potential.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Veracyte, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.